PRNewsWire
15 May 2026, 20:05 UTC · 19w ago
Verdict
Headline takes no side. We score ARAY +0.80 across two claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Accuray and the University of Wisconsin School of Medicine and Public Health have entered into a 10-year strategic master research agreement.
More positive than 65% of claims this week
The collaboration focuses on advancing personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 53% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company announced a 10-year strategic research collaboration with the University of Wisconsin-Madison to advance personalized cancer treatments.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1d ago
−20.3%
Price is moving against the score
$0.2151 vs $0.2700 close before publication (May 15) · not market-adjusted
ARAY chart →
